Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia

Leukemia & Lymphoma
Christopher PleyerClare Sun

Abstract

Ibrutinib and idelalisib are kinase inhibitors that have revolutionized the treatment of chronic lymphocytic leukemia (CLL). Capable of inducing durable remissions, these agents also modulate the immune system. Both ibrutinib and idelalisib abrogate the tumor-supporting microenvironment by disrupting cell-cell interactions, modulating the T-cell compartment, and altering the cytokine milieu. Ibrutinib also partially restores T-cell and myeloid defects associated with CLL. In contrast, immune-related adverse effects, including pneumonitis, colitis, hepatotoxicity, and infections are of particular concern with idelalisib. While opportunistic infections and viral reactivations occur with both ibrutinib and idelalisib, these complications are less common and less severe with ibrutinib, especially when used as monotherapy without additional immunosuppressive agents. This review discusses the impact of ibrutinib and idelalisib on the immune system, including infectious and auto-immune complications as well as their specific effects on the B-cell, T-cell, and myeloid compartment.

References

May 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R B WeissJ C Byrd
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J KeatingHagop Kantarjian
Mar 18, 2005·Annual Review of Immunology·Leslie J BergPamela L Schwartzberg
Jun 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Martin MelcherWilfried Ellmeier
Apr 10, 2009·PloS One·Klaartje KokBart Vanhaesebroeck
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tadeusz RobakSergey I Moiseev
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Jun 26, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Srinivas NagarajDmitry I Gabrilovich
Jan 24, 2014·The New England Journal of Medicine·Richard R FurmanSusan M O'Brien
Feb 19, 2014·The Journal of Experimental Medicine·Julio Gomez-RodriguezPamela L Schwartzberg
Feb 7, 2015·Cancer Treatment and Research·Clare Sun, Adrian Wiestner
Mar 3, 2015·Proceedings of the National Academy of Sciences of the United States of America·Idit Sagiv-BarfiRonald Levy
Jun 20, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarah E M HermanAdrian Wiestner
Aug 19, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin SkarzynskiAdrian Wiestner
Oct 9, 2015·The American Journal of Surgical Pathology·Anna-Sophie WeidnerRhonda K Yantiss
Dec 8, 2015·The New England Journal of Medicine·Jan A BurgerUNKNOWN RESONATE-2 Investigators

❮ Previous
Next ❯

Citations

Sep 12, 2018·Expert Review of Clinical Immunology·Wilma BarcelliniAnna Zaninoni
Jan 17, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Giuseppe Curigliano, Rashmi R Shah
Dec 7, 2019·Journal of Neurovirology·Alberto VogrigMariarosaria Valente
Feb 23, 2020·The Annals of Pharmacotherapy·Michael J BuegeKathryn T Maples
May 28, 2020·Leukemia·Philipp M Roessner, Martina Seiffert
Oct 30, 2019·Open Forum Infectious Diseases·Caroline ProtinLoic Ysebaert
Feb 12, 2021·Renal Failure·Csilla MarkóthJános Mátyus
May 4, 2021·Frontiers in Oncology·Maria Cristina PuzzoloRobin Foà
Jun 28, 2021·Hematology/oncology Clinics of North America·Clare Sun, Adrian Wiestner
Sep 25, 2021·Cancer Medicine·Maria Stefania InfanteUNKNOWN Grupo Español de Linfomas y Trasplante Autólogo de Medula Ósea (GELTAMO)

❮ Previous
Next ❯

Related Concepts

Related Feeds

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Related Papers

The New England Journal of Medicine
John C ByrdSusan O'Brien
Clinical Advances in Hematology & Oncology : H&O
Jennifer R Brown
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
F PanN Sengupta
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Farrukh T Awan, John C Byrd
© 2022 Meta ULC. All rights reserved